Vulval cancer and HPV vaccination in recurrent disease

KEY CLINICAL MESSAGE: A woman diagnosed with a recurrent vulval carcinoma after initial treatment with radiochemotherapy is presented. After three additional relapses she was vaccinated with Gardasil. She has had no relapses in her vulvar area for 39 months and an overall progression-free survival o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gustafson, L W, Gade, Melina, Blaakær, Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270702/
https://www.ncbi.nlm.nih.gov/pubmed/25548622
http://dx.doi.org/10.1002/ccr3.93
Descripción
Sumario:KEY CLINICAL MESSAGE: A woman diagnosed with a recurrent vulval carcinoma after initial treatment with radiochemotherapy is presented. After three additional relapses she was vaccinated with Gardasil. She has had no relapses in her vulvar area for 39 months and an overall progression-free survival of almost 24 months.

Ejemplares similares